Cargando…
_version_ 1783722543170977792
author Mesli, Farah
Dumont, Maëlle
Soria, Angèle
Groh, Matthieu
Turpin, Matthieu
Voiriot, Guillaume
Rafat, Cedric
Sallé, Delphine Staumont
Gibelin, Aude
Desnos, Cyrielle
author_facet Mesli, Farah
Dumont, Maëlle
Soria, Angèle
Groh, Matthieu
Turpin, Matthieu
Voiriot, Guillaume
Rafat, Cedric
Sallé, Delphine Staumont
Gibelin, Aude
Desnos, Cyrielle
author_sort Mesli, Farah
collection PubMed
description
format Online
Article
Text
id pubmed-8279918
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-82799182021-07-20 Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era Mesli, Farah Dumont, Maëlle Soria, Angèle Groh, Matthieu Turpin, Matthieu Voiriot, Guillaume Rafat, Cedric Sallé, Delphine Staumont Gibelin, Aude Desnos, Cyrielle J Allergy Clin Immunol Pract Correspondence and Replies American Academy of Allergy, Asthma & Immunology 2021-09 2021-07-15 /pmc/articles/PMC8279918/ /pubmed/34273579 http://dx.doi.org/10.1016/j.jaip.2021.06.047 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence and Replies
Mesli, Farah
Dumont, Maëlle
Soria, Angèle
Groh, Matthieu
Turpin, Matthieu
Voiriot, Guillaume
Rafat, Cedric
Sallé, Delphine Staumont
Gibelin, Aude
Desnos, Cyrielle
Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title_full Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title_fullStr Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title_full_unstemmed Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title_short Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
title_sort benralizumab: a potential tailored treatment for life-threatening dress in the covid-19 era
topic Correspondence and Replies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279918/
https://www.ncbi.nlm.nih.gov/pubmed/34273579
http://dx.doi.org/10.1016/j.jaip.2021.06.047
work_keys_str_mv AT meslifarah benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT dumontmaelle benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT soriaangele benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT grohmatthieu benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT turpinmatthieu benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT voiriotguillaume benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT rafatcedric benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT salledelphinestaumont benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT gibelinaude benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era
AT desnoscyrielle benralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era